NVEC Stock Analysis: NVE | NASDAQ
Semiconductors | NASDAQ, USA | Market Cap: 536m USD | 12M Return: 75.8% | US6294452064 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 10.5M
EPS Trend: -86.5%
Rev. Trend: -58.7%
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
NVE Corporation is a U.S.-based semiconductor company that develops and sells devices based on spintronics, a nanotechnology that uses electron spin to acquire, store, and transmit information. Its product portfolio includes magnetic sensors and spintronic couplers used in factory automation, medical devices, and power conversion applications, as well as DC-to-DC converters targeting industrial IoT (IIoT) and AIoT markets.
The company also generates revenue through research and development contracts and licensing of its magnetoresistive random access memory (MRAM) technology. NVE sells its products through a distributor-based sales channel and is headquartered in Eden Prairie, Minnesota, having been founded in 1989.
As a small-cap semiconductor firm, NVE operates in a niche segment of the broader chip industry, where specialty component manufacturers often focus on differentiated technologies like spintronics rather than competing in high-volume commodity chip markets. The companys reliance on third-party distributors is a standard go-to-market approach for specialized semiconductor vendors serving industrial and medical customers.
- Factory automation cycle drives standard sensor segment revenue
- Medical device approvals expand custom and medical sensor addressable market
- MRAM licensing royalties provide high-margin recurring revenue
- Capital returns through dividends supported by strong free cash flow
| Net Income: 18.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.25 > 0.02 and ΔFCF/TA 5.82 > 1.0 |
| NWC/Revenue: 109.3% < 20% (prev 97.40%; Δ 11.91% < -1%) |
| CFO/TA 0.27 > 3% & CFO 16.8m > Net Income 18.0m |
| Net Debt (-20.9m) to EBITDA (21.4m): -0.97 < 3 |
| Current Ratio: 23.72 > 1.5 & < 3 |
| Outstanding Shares: last quarter (4.85m) vs 12m ago 0.14% < -2% |
| Gross Margin: 79.26% > 18% (prev 82.37%; Δ -3.11% > 0.5%) |
| Asset Turnover: 49.75% > 50% (prev 39.65%; Δ 10.10% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBIT TTM and Interest Expense TTM) |
| A: 0.55 (Total Current Assets 35.7m - Total Current Liabilities 1.50m) / Total Assets 62.1m |
| B: 0.64 (Retained Earnings 39.9m / Total Assets 62.1m) |
| C: 0.33 (EBIT TTM 20.8m / Avg Total Assets 62.8m) |
| D: 25.58 (Book Value of Equity 59.8m / Total Liabilities 2.34m) |
| Altman-Z'' = 34.78 = AAA |
| DSRI: 2.50 (Receivables 7.00m/2.25m, Revenue 31.3m/25.2m) |
| GMI: 1.04 (GM 82.37% / 79.26%) |
| AQI: 0.68 (AQ_t 0.36 / AQ_t-1 0.53) |
| SGI: 1.24 (Revenue 31.3m / 25.2m) |
| TATA: 0.02 (NI 18.0m - CFO 16.8m) / TA 62.1m) |
| Beneish M = -1.77 (Cap -4..+1) = CCC |
As of October 05, 2026, the stock is trading at USD 111.42 with a total of 61,720 shares traded. Over the past week, the price has changed by +2.10%, over one month by +13.12%, over three months by +14.42% and over the past year by +75.82%.
Current recommended Stop Loss: 106.40 (which is 4.5% or 1.2 ATR below the current price).
NVE has no consensus analysts rating.
| Analysts Target Price | 79 | -29.1% |
P/E Trailing = 29.5467
P/E Forward = 21.0526
P/S = 17.1448
P/B = 8.8158
P/EG = 0.843
Revenue TTM = 31.3m USD
EBIT TTM = 20.8m USD
EBITDA TTM = 21.4m USD
Long Term Debt = 705k USD (estimated: total debt 906k - short term 201k)
Short Term Debt = 201k USD (from shortTermDebt, last quarter)
Debt = 906k USD (from shortLongTermDebtTotal, last quarter) (leases 906k already included)
Net Debt = -20.9m USD (calculated: Debt 906k - CCE 21.8m)
Enterprise Value = 515.1m USD (536.0m + Debt 906k - CCE 21.8m)
Interest Coverage Ratio = unknown (Ebit TTM 20.8m / Interest Expense TTM 0.0)
EV/FCF = 33.05x (Enterprise Value 515.1m / FCF TTM 15.6m)
FCF Yield = 3.03% (FCF TTM 15.6m / Enterprise Value 515.1m)
FCF Margin = 49.86% (FCF TTM 15.6m / Revenue TTM 31.3m)
Net Margin = 57.64% (Net Income TTM 18.0m / Revenue TTM 31.3m)
Gross Margin = 79.26% ((Revenue TTM 31.3m - Cost of Revenue TTM 6.48m) / Revenue TTM)
Gross Margin QoQ = 81.28% (prev 77.72%)
Tobins Q-Ratio = 8.29 (Enterprise Value 515.1m / Total Assets 62.1m)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 906k)
Taxrate = 15.21% (3.23m / 21.2m)
NOPAT = 17.6m (EBIT 20.8m * (1 - 15.21%))
Current Ratio = 23.72 (Total Current Assets 35.7m / Total Current Liabilities 1.50m)
Debt / Equity = 0.02 (Debt 906k / totalStockholderEquity, last quarter 59.8m)
Debt / EBITDA = -0.97 (Net Debt -20.9m / EBITDA 21.4m)
Debt / FCF = -1.34 (Net Debt -20.9m / FCF TTM 15.6m)
Total Stockholder Equity = 59.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 28.67% (Net Income 18.0m / Total Assets 62.1m)
RoE = 30.53% (Net Income TTM 18.0m / Total Stockholder Equity 59.0m)
RoCE = 34.83% (EBIT 20.8m / Capital Employed (Equity 59.0m + L.T.Debt 705k))
RoIC = 29.77% (NOPAT 17.6m / Invested Capital 59.3m)
WACC = 11.75% (E(536.0m)/V(536.9m) * Re(11.77%) + D(906k)/V(536.9m) * Rd(0.0%) * (1-Tc(0.15)))
Discount Rate = 11.77% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 50.05 | Cagr: 0.06%
[DCF] Terminal Value 67.79% ; FCFF base≈14.3m ; Y1≈16.3m ; Y5≈24.0m
[DCF] Fair Price = 50.94 (EV 225.5m - Net Debt -20.9m = Equity 246.4m / Shares 4.84m; r=11.75% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -86.51 | EPS CAGR: -16.24% | SUE: N/A | # QB: 0
Revenue Correlation: -58.75 | Revenue CAGR: -8.15% | SUE: N/A | # QB: 0